ISTA Reports Two Preliminary Results Of T-Pred Studies
ISTA Pharmaceuticals (ISTA) has reported preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred (prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension). Reportedly, the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.